Can Microneedle-Nanocarrier Platforms Deliver True Tolerogenic Immunotherapy for Psoriasis?

Feng M, Zhou H

Open source

DOI
10.3390/vaccines14090784
Published
2026 Sep 8
Container
Vaccines
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines14090784,
  title = {Can Microneedle-Nanocarrier Platforms Deliver True Tolerogenic Immunotherapy for Psoriasis?},
  author = {Feng M and Zhou H},
  year = {2026},
  journal = {Vaccines},
  doi = {10.3390/vaccines14090784},
  url = {https://doi.org/10.3390/vaccines14090784}
}

RIS

TY  - JOUR
TI  - Can Microneedle-Nanocarrier Platforms Deliver True Tolerogenic Immunotherapy for Psoriasis?
AU  - Feng M
AU  - Zhou H
PY  - 2026
JO  - Vaccines
DO  - 10.3390/vaccines14090784
UR  - https://doi.org/10.3390/vaccines14090784
ER  - 

APA

M, F., & H, Z. (2026). Can Microneedle-Nanocarrier Platforms Deliver True Tolerogenic Immunotherapy for Psoriasis?. Vaccines. https://doi.org/10.3390/vaccines14090784

Source records